Novo Nordisk A/s (NVO) stock valuation

$39.56 Nov 18, 2026 · market cap $176B

NEUTRAL6 months ago13/121 investors
i

Novo Nordisk A/s trades at $40. Our three models put it at $50–$85 (base $50): below all three.

Damodaran $85 · Cash Flow $77 · Buffett $50 · models run Nov 18, 2026

NEUTRAL · low confidence · May 6, 2026 · 6 months ago, may be out of date

13 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate NVOCreate free account →

Full open-source research report for NVO on DeepValues Research (CC BY 4.0)